Company
YnnoMed established a platform for the discovery and development of novel drugs, using computer-assisted technology to aid in the identification of unique drug targets, rational drug design, hit screening, lead optimisation, biological evaluation, pharmacological and toxicity assessment. The use of computer-assisted technology allows us to increase the rate of success, streamline the discovery process and significantly reduce costs in pre-clinical stages of drug R&D. The deployment of this technology has resulted in our successful identification of several promising first-in-class antimicrobial drug candidates. We also work on hit compound identification for other areas of biomedical research. By accelerating the R&D efforts of both academia and the pharmaceutical industry, our products are expected to enrich the future drug market.
Description
Ynno Med is a platform for the discovery and development of first-in-class drugs using computer-assisted technology
